Literature DB >> 15512792

Commentary: DNA base excision repair defects in human pathologies.

Guido Frosina1.   

Abstract

DNA base excision repair (BER) is the main pathway for repair of endogenous damage in human cells. It was expected that a number of degenerative diseases could derive from BER defects. On the contrary, the link between BER defects and human pathology is elusive and the literature is full of conflicting results. The fact that most studies have investigated DNA variations but not their functional consequences has probably contributed to this confusing picture. From a functional point of view, it is likely that gross BER defects are simply not compatible with life and only limited reductions can be observed. Notwithstanding those limits, the pathological consequences of partial BER defects might be widespread and significant at the population level. This starts to emerge in particular for colorectal and lung cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15512792     DOI: 10.1080/10715760400011445

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  13 in total

1.  Genetic variation in the base excision repair pathway and bladder cancer risk.

Authors:  Jonine D Figueroa; Núria Malats; Francisco X Real; Debra Silverman; Manolis Kogevinas; Stephen Chanock; Robert Welch; Mustafa Dosemeci; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Gemma Castaño-Vinyals; Nathaniel Rothman; Montserrat García-Closas
Journal:  Hum Genet       Date:  2007-01-03       Impact factor: 4.132

2.  Genome and cancer single nucleotide polymorphisms of the human NEIL1 DNA glycosylase: activity, structure, and the effect of editing.

Authors:  Aishwarya Prakash; Brittany L Carroll; Joann B Sweasy; Susan S Wallace; Sylvie Doublié
Journal:  DNA Repair (Amst)       Date:  2013-12-29

3.  Characterization of DNA polymerase beta splicing variants in gastric cancer: the most frequent exon 2-deleted isoform is a non-coding RNA.

Authors:  Valeria Simonelli; Mariarosaria D'Errico; Domenico Palli; Rajendra Prasad; Samuel H Wilson; Eugenia Dogliotti
Journal:  Mutat Res       Date:  2009-07-25       Impact factor: 2.433

4.  Chronic oxidative DNA damage due to DNA repair defects causes chromosomal instability in Saccharomyces cerevisiae.

Authors:  Natalya P Degtyareva; Lingling Chen; Piotr Mieczkowski; Thomas D Petes; Paul W Doetsch
Journal:  Mol Cell Biol       Date:  2008-06-30       Impact factor: 4.272

5.  Saccharomyces cerevisiae Apn1 mutation affecting stable protein expression mimics catalytic activity impairment: implications for assessing DNA repair capacity in humans.

Authors:  Lydia P Morris; Natalya Degtyareva; Clayton Sheppard; Lanier Heyburn; Andrei A Ivanov; Yoke Wah Kow; Paul W Doetsch
Journal:  DNA Repair (Amst)       Date:  2012-07-19

6.  Worldwide Distribution of Four SNPs in X-Ray and Repair and Cross-Complementing Group 1 (XRCC1).

Authors:  Haruo Takeshita; Junko Fujihara; Toshihiro Yasuda; Kaori Kimura-Kataoka
Journal:  Clin Transl Sci       Date:  2014-11-12       Impact factor: 4.689

Review 7.  Base excision repair and cancer.

Authors:  Susan S Wallace; Drew L Murphy; Joann B Sweasy
Journal:  Cancer Lett       Date:  2012-01-15       Impact factor: 8.679

8.  Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis.

Authors:  Claudia Tarlarini; Silvana Penco; Massimo Conio; Enzo Grossi
Journal:  Clin Exp Gastroenterol       Date:  2012-08-08

9.  Are SNP-Smoking Association Studies Needed in Controls? DNA Repair Gene Polymorphisms and Smoking Intensity.

Authors:  Zoraida Verde; Luis Reinoso; Luis Miguel Chicharro; Pilar Resano; Ignacio Sánchez-Hernández; Jose Miguel Rodríguez González-Moro; Fernando Bandrés; Félix Gómez-Gallego; Catalina Santiago
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

10.  Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.

Authors:  M Felicitas López-Cima; Patricia González-Arriaga; Laura García-Castro; Teresa Pascual; Manuel G Marrón; Xose S Puente; Adonina Tardón
Journal:  BMC Cancer       Date:  2007-08-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.